The l-α-Lysophosphatidylinositol/GPR55 System and Its Potential Role in Human Obesity

GPR55 is a putative cannabinoid receptor, and l-α-lysophosphatidylinositol (LPI) is its only known endogenous ligand. We investigated 1) whether GPR55 is expressed in fat and liver; 2) the correlation of both GPR55 and LPI with several metabolic parameters; and 3) the actions of LPI on human adipocy...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Moreno-Navarrete, José María, Catalán, Victoria, Whyte, Lauren, Díaz-Arteaga, Adenis, Vázquez-Martínez, Rafael, Rotellar, Fernando, Guzmán, Rocío, Gómez-Ambrosi, Javier, Pulido, Marina R., Russell, Wendy R., Imbernón, Mónica, Ross, Ruth A., Malagón, María M., Dieguez, Carlos, Fernández-Real, José Manuel, Frühbeck, Gema, Nogueiras, Ruben
Format: Artigo
Langue:Inglês
Publié: American Diabetes Association 2012
Sujets:
Metabolism
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3266411/
https://ncbi.nlm.nih.gov/pubmed/22179809
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db11-0649
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires